PrimeGlobal continues to monitor and assess new developments pertaining to the Novel Coronavirus. Keeping our members up to date on the latest information and approach to help reduce risk is a priority. You can find more information on PrimeGlobal's dedicated page HERE>

PrimeGlobal member firm KROST discusses the impact of R&D credit for businesses struggling with cash flow because of the Coronavirus Crisis. 

At the end of March, the U.S. government passed the Coronavirus Aid, Relief, and Economic Securities (“CARES”) Act to provide financial and emergency relief to American businesses, the American people, and the U.S. economy in whole. 

The objective of the stimulus package for businesses was to provide a lifeline of cash and liquidity that would assist in carrying these businesses through the next few weeks and months where much of the country is sheltering-in- place, and economic activity has screeched to a halt. 

The importance of cash to a business cannot be overstated. As a consultant in the tax and accounting space, one of KBKG’s primary objectives is to assist taxpayers in lowering effective tax rates and securing credits, which creates much needed cashflow for taxpayers of all sizes. One of the more lucrative options for accomplishing this objective is the research and development tax credit. 

The R&D credit provides taxpayers with a dollar-for-dollar reduction in their tax liability. The credit is both a federal and state incentive. When combined, the federal and state benefit can be up to $.15 of every dollar spent on qualifying research. The statute of limitations for securing the credit is generally three years from a federal perspective and four years for many states. Taxpayers that have been performing qualified research but did not secure the credits on previous tax returns are excited to learn of its existence and what it can mean to their business. This has become exceedingly important in 2020. Engaging in a research and development tax credit study that includes multiple years (e.g. tax years 2017, 2018, and 2019) can result in a refund of overpaid taxes and an influx of much needed cash to a business. While the CARES act provides avenues for securing loans from the government that can potentially be forgiven, the R&D credit is a permanent influx of capital now, and it can be secured well after the nation recovers from this pandemic.

Insight: In situations where a taxpayer’s research credit exceeds their tax liability, the federal statute allows taxpayers to carry their credits back for one year and then carry the credits forward for up to 20 years. Credits originating in an open tax year can potentially be taken back into a closed tax year when following the back one, forward 20 rule.

Leverage the Payroll Tax Credit

The research and development tax credit can also be used against payroll taxes. Qualified small businesses, defined as having less than five years’ worth of gross receipts and less than $5 million dollars in gross receipts for the year the election is made, can use up to $250,000 in federal research credits as an offset to the social security portion of the FICA payroll taxes. The election must be made on a timely filed tax return, including extension, and is effective the quarter after the tax return is filed.

Insight: The CARES Act contains a payroll tax deferral component where the payment of payroll taxes incurred between March 27, 2020, and December 31, 2020, will be considered timely paid if 50% of the incurred amounts are paid by December 31, 2021. The remaining 50% is paid by December 31, 2022. However, many taxpayers that qualify for the payroll portion of the research and development tax credit may prefer to use the credit as an offset of the tax for a couple of reasons. While a deferral is essentially an interest free loan, the amount incurred will still need to be paid versus permanently forgiven. Additionally, due to the criteria for qualification surrounding the payroll tax credit, taxpayers that fail to recognize the incentive this year may not qualify for it in future years due to either having revenue for more than five years or exceeding the $5 million threshold for revenue.

The research credit has historically been an incentive geared towards driving innovation and reinvesting in the country. The majority of qualified research expenses come from the wages paid to employees. Fundamentally, the objective of the research and development tax credit accomplishes much of what the CARES act attempts to do: provide a means for business continuity and growth.

Content by:

KROST Certified Public Accountants & Consultants

Established in 1939 in Pasadena, California, KROST, is a full-service Certified Public Accounting and Consulting firm serving clients across various industries. Our focus is recognizing opportunities and creating value for our clients by equipping them with the tools to make better business and financial decisions for the future. As trusted advisors, our clients depend on us to provide timely information, innovative solutions, and result-driven teamwork to ensure success.

Learn more